Biopol Chemicals Limited Appoints New Directors, Reconstitutes Committees Following Board Meeting
Biopol Chemicals Limited has announced the appointment of new directors following a meeting of its Board of Directors held on June 11, 2026. The company approved the appointments of Ms. Vandan Vij Sarkar and Mr. Sukhomoy Das to the Board, leading to the necessary reconstitution of various corporate committees.The Board approved the appointment of Ms. Vandan Vij Sarkar as an Additional Director in the category of Non-Executive Director. Ms. Sarkar's appointment is effective from June 11, 2026, and she shall hold office up to the date of the next General Meeting or within a period of three months from her appointment, whichever is earlier.
The company also approved the appointment of Mr. Sukhomoy Das as an Additional Non-Executive Independent Director, effective from June 11, 2026. Mr. Das will hold office for a term of five consecutive years, subject to the approval of the shareholders. His tenure period is capped by either the date of the next General Meeting or three months from his appointment, whichever occurs first. The Board confirmed that Mr. Das meets all independence criteria as prescribed under relevant company laws.
Mr. Das brings extensive experience in governance, risk oversight, and compliance. As a highly experienced healthcare professional and governance expert, he possesses over 30 years of experience spanning clinical leadership, public policy, and corporate governance. He holds qualifications in Medicine from India and the United Kingdom and an LL.B. degree from the University of Strathclyde in Glasgow, UK.
Key details regarding the appointment of Mr. Sukhomoy Das are presented below:
| Particulars | Details |
|---|---|
| Reason for Change | Appointment as Additional Non Executive Independent Director. |
| Date and Term | Date of Appointment: June 11, 2026. Term: Five consecutive years (subject to shareholder approval). |
| Professional Profile | Dr. Das has served in senior clinical roles within NHS Scotland since 1996, specializing in neurovascular medicine. He is recognized for his contributions to whistleblowing governance and public accountability. He currently serves as a Non-Executive Director on the Board of NHS Ayrshire and Arran. |
In light of these appointments, the company's Board of Directors has formally reconstituted various corporate committees to comply with regulatory requirements. The meeting concluded after considering all material matters related to the new appointments.
BIOPOL Stock Price Movement
Biopol Chemicals Limited shares settled lower in the market today, shedding 0.79% and closing at ₹92.40. The stock traded within an intraday range defined by a high of ₹96.00 and a low of ₹90.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.